(0.25%) 5 193.52 points
(0.17%) 38 918 points
(0.17%) 16 377 points
(-0.40%) $78.17
(0.23%) $2.20
(0.13%) $2 334.20
(-0.16%) $27.57
(2.44%) $988.40
(-0.01%) $0.928
(0.42%) $10.87
(0.16%) $0.797
(0.11%) $91.45
0.66% CHF 521.80
Live Chart Being Loaded With Signals
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions...
Stats | |
---|---|
Volumen de hoy | 67 754.00 |
Volumen promedio | 203 636 |
Capitalización de mercado | 38.76B |
EPS | CHF0 ( 2024-01-25 ) |
Próxima fecha de ganancias | ( CHF0 ) 2024-07-19 |
Last Dividend | CHF0 ( N/A ) |
Next Dividend | CHF0 ( N/A ) |
P/E | 34.33 |
ATR14 | CHF0.242 (0.05%) |
Volumen Correlación
Lonza Group AG Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lonza Group AG Correlación - Moneda/Commodity
Lonza Group AG Finanzas
Annual | 2023 |
Ingresos: | CHF6.72B |
Beneficio Bruto: | CHF1.82B (27.04 %) |
EPS: | CHF8.88 |
FY | 2023 |
Ingresos: | CHF6.72B |
Beneficio Bruto: | CHF1.82B (27.04 %) |
EPS: | CHF8.88 |
FY | 2022 |
Ingresos: | CHF6.22B |
Beneficio Bruto: | CHF2.30B (36.96 %) |
EPS: | CHF16.37 |
FY | 2021 |
Ingresos: | CHF5.41B |
Beneficio Bruto: | CHF2.11B (39.01 %) |
EPS: | CHF39.65 |
Financial Reports:
No articles found.
Lonza Group AG
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico